2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 129 filers reported holding 2SEVENTY BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44,261 | -85.7% | 11,291 | -63.0% | 0.00% | -100.0% |
Q2 2023 | $308,680 | -0.8% | 30,502 | -0.0% | 0.00% | 0.0% |
Q1 2023 | $311,192 | +122.3% | 30,509 | +187.4% | 0.00% | 0.0% |
Q2 2022 | $140,000 | -17.2% | 10,616 | +6.9% | 0.00% | 0.0% |
Q1 2022 | $169,000 | -22.1% | 9,932 | +17.6% | 0.00% | 0.0% |
Q4 2021 | $217,000 | – | 8,448 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 5,953,825 | $23,338,994 | 3.82% |
Newtyn Management, LLC | 3,076,490 | $12,059,841 | 2.98% |
DAFNA Capital Management LLC | 1,447,465 | $5,674,063 | 1.76% |
CHI Advisors LLC | 1,002,007 | $3,927,867 | 1.56% |
AlphaCentric Advisors LLC | 657,500 | $2,577,400 | 1.46% |
Casdin Capital, LLC | 2,023,913 | $7,933,739 | 0.88% |
Madison Avenue Partners, LP | 1,494,125 | $5,856,970 | 0.83% |
Bain Capital Life Sciences Investors, LLC | 1,408,901 | $5,522,892 | 0.62% |
Eversept Partners, LP | 1,453,378 | $5,697,242 | 0.48% |
Engine Capital Management, LP | 341,870 | $1,340,130 | 0.30% |